Spontaneous apoptosis of blood dendritic cells in patients with breast cancer
2006

Apoptosis of Blood Dendritic Cells in Breast Cancer Patients

Sample size: 28 publication Evidence: moderate

Author Information

Author(s): Pinzon-Charry Alberto, Maxwell Tammy, McGuckin Michael A, Schmidt Chris, Furnival Colin, López J Alejandro

Primary Institution: Queensland Institute of Medical Research

Hypothesis

Tumor products induce apoptosis in blood dendritic cells (DCs) in patients with breast cancer.

Conclusion

The study shows that blood dendritic cells in breast cancer patients undergo spontaneous apoptosis, which can be mitigated by ex vivo conditioning.

Supporting Evidence

  • Patients with breast cancer had a higher proportion of apoptotic blood dendritic cells compared to healthy volunteers.
  • Tumor-derived supernatants induced apoptosis in blood dendritic cells.
  • CD40 stimulation protected blood dendritic cells from apoptosis.

Takeaway

In patients with breast cancer, more blood cells that help fight infections and tumors are dying than in healthy people, but we can help keep them alive with certain treatments.

Methodology

The study assessed apoptosis in blood dendritic cells using Annexin-V and TUNEL assays on peripheral blood mononuclear cells from patients and healthy volunteers.

Participant Demographics

13 female patients aged 40 to 75 with early stage breast cancer and 15 healthy female volunteers aged 24 to 73.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/bcr1361

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication